Literature DB >> 26869278

Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.

Xiaoxiao Yang1, Aiwu Lin1, Na Jiang1, Hao Yan1, Zhaohui Ni1, Jiaqi Qian1, Wei Fang1.   

Abstract

AIMS: Interleukin-6 (IL-6) is a vital inflammatory factor in the peritoneal cavity of peritoneal dialysis (PD) patients. Because intraperitoneal inflammation is closely associated with angiogenesis, we sought to explore the effect of IL-6 on vascular endothelial growth factor (VEGF) synthesis and its transduction pathway in mesothelial cells.
METHODS: Human mesothelial cells (Met-5A) were incubated with different concentrations of glucose and mannitol, and the effect of glucose and mannitol on the expression of IL-6 was determined. Then, the cells were stimulated by IL-6 with or without two soluble receptors of IL-6 (sIL-6R or sgp130), and VEGF synthesis was detected. Finally, the cells were incubated with IL-6/sIL-6R combined with or without the inhibitor of Janus kinases (JAK) AG490. The phosphorylation of the signal transducer and activator of transcription 3 (STAT3) and its intracellular translocation were examined.
RESULTS: 1. High glucose and mannitol could upregulate IL-6 mRNA expression and IL-6 secretion in mesothelial cells significantly, and there was no difference of its effect between high glucose and mannitol. 2. Met-5A was a cell line with a single IL-6 receptor. The IL-6/sIL-6R complex induced VEGF synthesis of mesothelial cells, which was alleviated by sgp130 or AG490. IL-6 trans-signalling could induce the phosphorylation of STAT3, which is recruited to the cellular nucleus of Met-5A cells.
CONCLUSION: The present study might provide evidence that high glucose upregulates IL-6 synthesis in Met-5A cells, to some extent, depending on its osmolality and that IL-6 trans-signalling could induce VEGF synthesis partly dependent on the JAK/STAT3 pathway.
© 2016 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  IL-6 trans-signalling; JAK/STAT3; peritoneal dialysis; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 26869278     DOI: 10.1111/nep.12746

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  11 in total

Review 1.  Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.

Authors:  Zhen Zhang; Na Jiang; Zhaohui Ni
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

2.  Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.

Authors:  Gaurav Kumar; S Nahum Goldberg; Svetlana Gourevitch; Tatyana Levchenko; Vladimir Torchilin; Eithan Galun; Muneeb Ahmed
Journal:  Radiology       Date:  2017-09-06       Impact factor: 11.105

Review 3.  STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation.

Authors:  Hardeep Singh Tuli; Katrin Sak; Ashif Iqubal; Vivek Kumar Garg; Mehmet Varol; Uttam Sharma; Abhishek Chauhan; Mukerrem Betul Yerer; Kuldeep Dhama; Manju Jain; Aklank Jain
Journal:  Mol Biol Rep       Date:  2022-04-26       Impact factor: 2.742

4.  Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion.

Authors:  Ken Tawara; Hannah Scott; Jacqueline Emathinger; Alex Ide; Ryan Fox; Daniel Greiner; Dollie LaJoie; Danielle Hedeen; Madhuri Nandakumar; Andrew J Oler; Ryan Holzer; Cheryl Jorcyk
Journal:  Transl Oncol       Date:  2018-11-12       Impact factor: 4.243

5.  Therapeutic Potential of Exosomal circRNA Derived from Synovial Mesenchymal Cells via Targeting circEDIL3/miR-485-3p/PIAS3/STAT3/VEGF Functional Module in Rheumatoid Arthritis.

Authors:  Juan Zhang; Yue Zhang; Yeye Ma; Lili Luo; Maolin Chu; Zhiyi Zhang
Journal:  Int J Nanomedicine       Date:  2021-12-03

6.  Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway.

Authors:  Yunchao Xin; Xiaoling Shang; Xiaoran Sun; Yachao Liu; Guogang Xu; Gang Xue
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-14       Impact factor: 2.629

7.  STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.

Authors:  Xiaoxiao Yang; Manchen Bao; Yi Fang; Xiaofang Yu; Jun Ji; Xiaoqiang Ding
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

Review 8.  The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.

Authors:  Peng Gao; Na Niu; Tianshu Wei; Hideto Tozawa; Xiaocui Chen; Caiqing Zhang; Jiandong Zhang; Youichiro Wada; Carolyn M Kapron; Ju Liu
Journal:  Oncotarget       Date:  2017-08-04

Review 9.  STAT3 in Skeletal Muscle Function and Disorders.

Authors:  Eleonora Guadagnin; Davi Mázala; Yi-Wen Chen
Journal:  Int J Mol Sci       Date:  2018-08-02       Impact factor: 5.923

Review 10.  Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?

Authors:  Anna Jaśkiewicz; Tomasz Domoradzki; Beata Pająk
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.